Idera Pharmaceuticals Inc news

   Watch this stock
Showing stories 1 - 10 of about 85   

Articles published

IDRA 2.53 -0.11 (-4.17%)
price chart
Hot News: Idera Pharmaceuticals (NASDAQ:IDRA), Micron (NASDAQ:MU ...
At Idera Pharmaceuticals, Inc. (NASDAQ:IDRA)'s 2014 annual meeting of stockholders held on June 9, 2014 the Company's stockholders approved an amendment to the Company's 2013 Stock Incentive Plan to increase the number of shares authorized for ...
Eye-Catching Stocks - Idera Pharmaceuticals Inc (NASDAQ:IDRA), ImmunoGen ...
Birmingham, West Midlands - (TechSonian) �July 26, 2014 - Idera Pharmaceuticals Inc (NASDAQ:IDRA) is a clinical stage biotechnology company, is engaged in the discovery and development of novel therapeutics that modulate immune responses ...
Related articles »  
Watch List - Idera Pharmaceuticals Inc (NASDAQ:IDRA), Kinross Gold ...
Las Vegas, NV - July- 22 2014 - (TechSonian) - Idera Pharmaceuticals Inc (NASDAQ:IDRA) a clinical stage biotechnology company, is engaged in the discovery and development of novel therapeutics that modulate immune responses through toll-like ...
Related articles »  
Stocks Alert �IAMGOLD Corp (USA) (NYSE:IAG), Idera Pharmaceuticals Inc ...
Idera Pharmaceuticals Inc (NASDAQ:IDRA) is a clinical stage biotechnology company, is engaged in the discovery and development of novel therapeutics that modulate immune responses through toll-like receptors (TLRs) in the United States.
Related articles »  
Lower Notes Biotech Stocks- Idera Pharmaceuticals Inc (NASDAQ:IDRA), Gilead ...
Idera Pharmaceuticals Inc (NASDAQ:IDRA) [Trend Analysis]reported that it will be added to the Russell 3000 and Russell 2000 Indexes when Russell Investments reconstitutes its comprehensive set of U.S.
Related articles »  
News Buzz - Idera Pharmaceuticals Inc (NASDAQ:IDRA), MBIA Inc. (NYSE:MBI ...
Idera Pharmaceuticals Inc (NASDAQ:IDRA) , a clinical stage biotechnology company, is engaged in the discovery and development of novel therapeutics that modulate immune responses through toll-like receptors (TLRs) in the United States.
Related articles »  
Mid Day Movers: Plug Power Inc. (NASDAQ:PLUG), Idera Pharmaceuticals Inc ...
Lakeway, NY - (MARKET NEWS CALL) - 7/21/2014� Specialpennystockalert.com, an investment community with a special focus on updating investors with recent news on the U.S.
Related articles »  
What's Behind Biotech Selloff? � Idera Pharmaceuticals (IDRA), Merrimack ...
Idera Pharmaceuticals Inc (NASDAQ:IDRA), Merrimack Pharmaceuticals Inc (NASDAQ:MACK), Lexicon Pharmaceuticals, Inc. (NASDAQ:LXRX) and AVEO Pharmaceuticals, Inc. (NASDAQ:AVEO) all were making big declines on valuation concerns.
Eye-Catching Stocks -Progenics Pharmaceuticals, Inc. (PGNX), Peregrine ...  Techsonian (press release)
Biotech Losers: Exelixis (NASDAQ:EXEL), Ariad Pharmaceuticals (NASDAQ ...  Crazy Joys
Related articles »  
Bearish Runners - Amkor Technology, Inc. (NASDAQ:AMKR), Idera ...
Idera Pharmaceuticals Inc (NASDAQ:IDRA) declared the pricing of an underwritten public offering of 6,841,250 shares of common stock for a public offering price of $4.00 for each share, and pre-funded warrants to purchase up to an aggregate of 2,158,750 ...
Related articles »  
Stocks to Track - Idera Pharmaceuticals Inc (IDRA), Amkor Technology, Inc ...
Las Vegas, NV - July 02, 2014 - (TechSonian) �Idera Pharmaceuticals Inc (NASDAQ:IDRA) a clinical stage biotechnology company, is engaged in the discovery and development of novel therapeutics that modulate immune responses through toll-like ...
Related articles »